Select Publications

Journal articles

Paul CL; Warren G; Vinod S; Meiser B; Stone E; Barker D; White K; McLennan J; Day F; McCarter K; McEnallay M; Tait J; Canfell K; Weber M; Segan C, 2021, 'Care to Quit: a stepped wedge cluster randomised controlled trial to implement best practice smoking cessation care in cancer centres', Implementation Science, vol. 16, pp. 23, http://dx.doi.org/10.1186/s13012-021-01092-5

Meiser B; Kaur R; Morrow A; Peate M; Wong WKT; McPike E; Cops E; Nichols C; Austin R; Fine M; Thrupp L; Ward R; Macrae F; Hiller JE; Trainer AH; Mitchell G; Susman R; Pachter N; Goodwin A; James P; Mascarenhas L; Morton C; Shanley S; Young MA; Andrews L; Morrow EA; Tucker K; James P; Lindeman G; Mascarenhas L; Morton C; Field M; Goodwin A; Monnik M; Poplawski N; Delatycki M; John T; Harris M; Kerr R; Vora B, 2021, 'Impact of national guidelines on use of BRCA1/2 germline testing, risk management advice given to women with pathogenic BRCA1/2 variants and uptake of advice', Hereditary Cancer in Clinical Practice, vol. 19, pp. 24, http://dx.doi.org/10.1186/s13053-021-00180-3

Thavaneswaran S; Ballinger M; Butow P; Meiser B; Goldstein D; Lin F; Napier C; Thomas D; Best M, 2021, 'The experiences and needs of Australian medical oncologists in integrating comprehensive genomic profiling into clinical care: a nation-wide survey', Oncotarget, vol. 12, pp. 2169 - 2176, http://dx.doi.org/10.18632/oncotarget.28076

Das Gupta K; Gregory G; Meiser B; Kaur R; Scheepers-Joynt M; McInerny S; Taylor S; Barlow-Stewart K; Antill Y; Salmon L; Smyth C; McInerney-Leo A; Young MA; James PA; Yanes T, 2021, 'Communicating polygenic risk scores in the familial breast cancer clinic', Patient Education and Counseling, vol. 104, pp. 2512 - 2521, http://dx.doi.org/10.1016/j.pec.2021.02.046

Smit AK; Sharman AR; Espinoza D; Wallingford C; Young MA; Dunlop K; Tiller J; Newson AJ; Meiser B; Cust AE; Yanes T, 2021, 'Knowledge, views and expectations for cancer polygenic risk testing in clinical practice: A cross-sectional survey of health professionals', Clinical Genetics, vol. 100, pp. 430 - 439, http://dx.doi.org/10.1111/cge.14025

Hemming P; Kaur R; Meiser B; McKinley J; Young MA; James PA; Forrest LE, 2021, 'Oncologists’ perspectives of telephone genetic counseling to facilitate germline BRCA1/2 testing for their patients with high-grade serous ovarian cancer', Journal of Community Genetics, vol. 12, pp. 449 - 457, http://dx.doi.org/10.1007/s12687-021-00530-7

Cousens NE; Tiller J; Meiser B; Barlow-Stewart K; Rowley S; Ko YA; Mahale S; Campbell IG; Kaur R; Bankier A; Burnett L; Jacobs C; James PA; Trainer A; Neil S; Delatycki MB; Andrews L, 2021, 'Evaluation of two population screening programmes for BRCA1/2 founder mutations in the Australian Jewish community: A protocol paper', BMJ Open, vol. 11, pp. e041186, http://dx.doi.org/10.1136/bmjopen-2020-041186

Lee DSC; Meiser B; Mariapun S; Hassan T; Yip CH; Mohd Taib NA; Teo SH; Thong MK; Yoon SY, 2021, 'Communication about positive BRCA1 and BRCA2 genetic test results and uptake of testing in relatives in a diverse Asian setting', Journal of Genetic Counseling, vol. 30, pp. 720 - 729, http://dx.doi.org/10.1002/jgc4.1360

Willis AM; Smith SK; Meiser B; James PA; Ballinger ML; Thomas DM; Yanes T; Young MA, 2021, 'Influence of lived experience on risk perception among women who received a breast cancer polygenic risk score: ‘Another piece of the pie’', Journal of Genetic Counseling, vol. 30, pp. 849 - 860, http://dx.doi.org/10.1002/jgc4.1384

Smit AK; Bartley N; Best MC; Napier CE; Butow P; Newson AJ; Tucker K; Ballinger ML; Thomas DM; Jacobs C; Meiser B; Goldstein D; Savard J; Juraskova I, 2021, 'Family communication about genomic sequencing: A qualitative study with cancer patients and relatives', Patient Education and Counseling, vol. 104, pp. 944 - 952, http://dx.doi.org/10.1016/j.pec.2020.10.022

Hickey M; Moss KM; Brand A; Wrede CD; Domchek SM; Meiser B; Mishra GD; Joffe H, 2021, 'What happens after menopause? (WHAM): A prospective controlled study of depression and anxiety up to 12 months after premenopausal risk-reducing bilateral salpingo-oophorectomy', Gynecologic Oncology, vol. 161, pp. 527 - 534, http://dx.doi.org/10.1016/j.ygyno.2021.02.001

Islam RM; Davis SR; Bell RJ; Tejada-Berges T; Wrede CD; Domchek SM; Meiser B; Kirk J; Krejany EO; Hickey M, 2021, 'A prospective controlled study of sexual function and sexually related personal distress up to 12 months after premenopausal risk-reducing bilateral salpingo-oophorectomy', Menopause (New York, N.Y.), vol. 28, pp. 748 - 755, http://dx.doi.org/10.1097/GME.0000000000001766

Yanes T; Meiser B; Kaur R; Young MA; Mitchell PB; Scheepers-Joynt M; McInerny S; Taylor S; Barlow-Stewart K; Antill Y; Salmon L; Smyth C; Betz-Stablein B; James PA, 2021, 'Breast cancer polygenic risk scores: a 12-month prospective study of patient reported outcomes and risk management behavior', Genetics in Medicine, http://dx.doi.org/10.1038/s41436-021-01288-6

Napier CE; Davies G; Butow PN; Schlub TE; Best MC; Bartley N; Juraskova I; Meiser B; Tucker KM; Biesecker BB; Thomas DM; Ballinger ML, 2021, 'Cancer patient knowledge about and behavioral intentions after germline genome sequencing', Patient Education and Counseling, http://dx.doi.org/10.1016/j.pec.2021.07.004

Bartley N; Best MC; Biesecker BB; Fisher A; Goldstein D; Meiser B; Thomas DM; Ballinger ML; Butow P, 2021, 'Effectively communicating comprehensive tumor genomic profiling results: Mitigating uncertainty for advanced cancer patients', Patient Education and Counseling, http://dx.doi.org/10.1016/j.pec.2021.05.018

Bartley N; Davies G; Butow P; Napier CE; Schlub T; Ballinger ML; Thomas DM; Juraskova I; Meiser B; Best MC, 2021, 'Fear of cancer recurrence in patients undergoing germline genome sequencing', Supportive Care in Cancer, http://dx.doi.org/10.1007/s00520-021-06311-9

Butow P; Müller F; Napier CE; Bartley N; Ballinger ML; Biesecker B; Juraskova I; Meiser B; Schlub TE; Thomas DM; Goldstein D; Best MC; Newson A; Tucker K; Vines R; Vines K; Kirk J; Young MA; Savard J; Jacobs C, 2021, 'Longitudinal patterns in fear of cancer progression in patients with rare, advanced cancers undergoing comprehensive tumour genomic profiling', Psycho-Oncology, http://dx.doi.org/10.1002/pon.5764

Meiser B; Woodward P; Gleeson M; Kentwell M; Fan HM; Antill Y; Butow PN; Boyle F; Best M; Taylor N; Bell K; Tucker K, 2021, 'Pilot study of an online training program to increase genetic literacy and communication skills in oncology healthcare professionals discussing BRCA1/2 genetic testing with breast and ovarian cancer patients', Familial Cancer, http://dx.doi.org/10.1007/s10689-021-00261-1

Gregory G; Das Gupta K; Meiser B; Barlow-Stewart K; Geelan-Small P; Kaur R; Scheepers-Joynt M; McInerny S; Taylor S; Antill Y; Salmon L; Smyth C; Young MA; James PA; Yanes T, 2021, 'Polygenic risk in familial breast cancer: Changing the dynamics of communicating genetic risk', Journal of Genetic Counseling, http://dx.doi.org/10.1002/jgc4.1458

Butow P; Davies G; Napier CE; Bartley N; Ballinger ML; Biesecker B; Juraskova I; Meiser B; Schlub T; Thomas DM; Goldstein D; Best MC, 2021, 'Value of whole-genome sequencing to Australian cancer patients and their first-degree relatives participating in a genomic sequencing study', Journal of Genetic Counseling, http://dx.doi.org/10.1002/jgc4.1455

Bartley N; Best M; Jacobs C; Juraskova I; Newson AJ; Savard J; Meiser B; Ballinger ML; Thomas DM; Biesecker B; Butow P, 2020, 'Cancer patients' views and understanding of genome sequencing: A qualitative study', Journal of Medical Genetics, vol. 57, pp. 671 - 676, http://dx.doi.org/10.1136/jmedgenet-2019-106410

Meiser B; Kaur R; Kirk J; Morrow A; Peate M; Wong WKT; McPike E; Cops E; Dowson C; Austin R; Fine M; Thrupp L; Ward R; Macrae F; Hiller JE; Trainer AH; Mitchell G; Susman R; Pachter N; Goodwin A; James P; Mascarenhas L; Morton C; Shanley S; Young MA; Andrews L; Morrow EA; Tucker K; Lindeman G; Field M; Monnik M; Poplawski N; Delatycki M; John T; Harris M; Kerr R; Vora B, 2020, 'Evaluation of implementation of risk management guidelines for carriers of pathogenic variants in mismatch repair genes: a nationwide audit of familial cancer clinics', Familial Cancer, vol. 19, pp. 337 - 346, http://dx.doi.org/10.1007/s10689-020-00183-4

Yanes T; Kaur R; Meiser B; Scheepers-Joynt M; McInerny S; Barlow-Stewart K; Antill Y; Salmon L; Smyth C; James PA; Young MA, 2020, 'Women’s responses and understanding of polygenic breast cancer risk information', Familial Cancer, vol. 19, pp. 297 - 306, http://dx.doi.org/10.1007/s10689-020-00185-2

Davies G; Butow P; Napier CE; Bartley N; Juraskova I; Meiser B; Ballinger ML; Thomas DM; Schlub TE; Best MC, 2020, 'Advanced Cancer Patient Knowledge of and Attitudes towards Tumor Molecular Profiling', Translational Oncology, vol. 13, pp. 100799, http://dx.doi.org/10.1016/j.tranon.2020.100799

Gleeson M; Kentwell M; Meiser B; Do J; Nevin S; Taylor N; Barlow-Stewart K; Kirk J; James P; Scott CL; Williams R; Gamet K; Burke J; Murphy M; Antill YC; Pearn A; Pachter N; Ebzery C; Poplawski N; Friedlander M; Tucker KM, 2020, 'The development and evaluation of a nationwide training program for oncology health professionals in the provision of genetic testing for ovarian cancer patients', Gynecologic Oncology, vol. 158, pp. 431 - 439, http://dx.doi.org/10.1016/j.ygyno.2020.05.001

Meiser B; Guo XY; Putt S; Fullerton JM; Schofield PR; Mitchell PB; Yanes T, 2020, 'Psychosocial implications of living with familial risk of a psychiatric disorder and attitudes to psychiatric genetic testing: A systematic review of the literature', American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, vol. 183, pp. 277 - 288, http://dx.doi.org/10.1002/ajmg.b.32786

Butow P; Davies G; Napier C; Thomas DM; Bartley N; Goldstein D; Ballinger ML; Juraskova I; Schlub TE; Tucker K; Meiser B; Young M-A, 2020, 'Return of results after somatic tumor mutation profiling in advanced cancer: Psychological impacts.', Journal of Clinical Oncology, vol. 38, pp. 1541 - 1541, http://dx.doi.org/10.1200/jco.2020.38.15_suppl.1541

Butow P; Davies G; Napier CE; Schlub T; Best MC; Bartley N; Juraskova I; Meiser B; Ballinger ML; Biesecker B; Goldstein D; Thomas DM, 2020, 'Assessment of the Value of Tumor Variation Profiling Perceived by Patients with Cancer', JAMA Network Open, vol. 3, pp. e204721, http://dx.doi.org/10.1001/jamanetworkopen.2020.4721

McInerney-Leo AM; West J; Meiser B; West M; Brown MA; Duncan E, 2020, 'Causal Attributions in an Australian Aboriginal Family With Marfan Syndrome: A Qualitative Study', Frontiers in Genetics, vol. 11, pp. 461, http://dx.doi.org/10.3389/fgene.2020.00461

Lo LE; Kaur R; Meiser B; Green MJ, 2020, 'Risk of schizophrenia in relatives of individuals affected by schizophrenia: A meta-analysis', PSYCHIATRY RESEARCH, vol. 286, http://dx.doi.org/10.1016/j.psychres.2020.112852

Putt S; Yanes T; Meiser B; Kaur R; Fullerton JM; Barlow-Stewart K; Schofield PR; Toma C; Peay H; Mitchell PB, 2020, 'Exploration of experiences with and understanding of polygenic risk scores for bipolar disorder', Journal of Affective Disorders, vol. 265, pp. 342 - 350, http://dx.doi.org/10.1016/j.jad.2020.01.037

Yanes T; Meiser B; Kaur R; Scheepers-Joynt M; McInerny S; Taylor S; Barlow-Stewart K; Antill Y; Salmon L; Smyth C; Young MA; James PA, 2020, 'Uptake of polygenic risk information among women at increased risk of breast cancer', Clinical Genetics, vol. 97, pp. 492 - 501, http://dx.doi.org/10.1111/cge.13687

Yanes T; Young MA; Meiser B; James PA, 2020, 'Clinical applications of polygenic breast cancer risk: A critical review and perspectives of an emerging field', Breast Cancer Research, vol. 22, pp. 21, http://dx.doi.org/10.1186/s13058-020-01260-3

Best MC; Butow P; Jacobs C; Savard J; Biesecker B; Ballinger ML; Bartley N; Davies G; Napier CE; Smit AK; Thomas DM; Newson AJ, 2020, 'Who should access germline genome sequencing? A mixed methods study of patient views', Clinical Genetics, vol. 97, pp. 329 - 337, http://dx.doi.org/10.1111/cge.13664

O’Neill RS; Meiser B; Emmanuel S; Williams DB; Stoita A, 2020, 'Long-term positive psychological outcomes in an Australian pancreatic cancer screening program', Familial Cancer, vol. 19, pp. 23 - 35, http://dx.doi.org/10.1007/s10689-019-00147-3

Li A; Geyer FC; Blecua P; Lee JY; Selenica P; Brown DN; Pareja F; Lee SSK; Kumar R; Rivera B; Bi R; Piscuoglio S; Wen HY; Lozada JR; Gularte-Mérida R; Cavallone L; Aghmesheh M; Amor D; Andrews L; Antill Y; Balleine R; Beesley J; Blackburn A; Bogwitz M; Brown M; Burgess M; Burke J; Butow P; Caldon L; Campbell I; Christian A; Clarke C; Cohen P; Crook A; Cui J; Cummings M; Dawson SJ; De Fazio A; Delatycki M; Dobrovic A; Dudding T; Duijf P; Edkins E; Edwards S; Farshid G; Fellows A; Field M; Flanagan J; Fong P; Forbes J; Forrest L; Fox S; French J; Friedlander M; Ortega DG; Gattas M; Giles G; Gill G; Gleeson M; Greening S; Haan E; Harris M; Hayward N; Hickie I; Hopper J; Hunt C; James P; Jenkins M; Kefford R; Kentwell M; Kirk J; Kollias J; Lakhani S; Lindeman G; Lipton L; Lobb L; Lok S; Macrea F; Mann G; Marsh D; McLachlan SA; Meiser B; Milne R; Nightingale S; O’Connell S; Pachter N; Patterson B; Phillips K; Saleh M; Salisbury E; Saunders C; Saunus J; Scott C; Scott R; Sexton A; Shelling A; Simpson P; Spigelman A; Spurdle M; Stone J, 2019, 'Homologous recombination DNA repair defects in PALB2-associated breast cancers', npj Breast Cancer, vol. 5, http://dx.doi.org/10.1038/s41523-019-0115-9

Lázaro-Muñoz G; Sabatello M; Huckins L; Peay H; Degenhardt F; Meiser B; Lencz T; Soda T; Docherty A; Crepaz-Keay D; Austin J; Peterson RE; Davis LK, 2019, 'International Society of Psychiatric Genetics Ethics Committee: Issues facing us', American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, vol. 180, pp. 543 - 554, http://dx.doi.org/10.1002/ajmg.b.32736

Moldovan R; McGhee KA; Coviello D; Hamang A; Inglis A; Ingvoldstad Malmgren C; Johansson-Soller M; Laurino M; Meiser B; Murphy L; Paneque M; Papsuev O; Pawlak J; Rovira Moreno E; Serra-Juhe C; Shkedi-Rafid S; Laing N; Voelckel MA; Watson M; Austin JC, 2019, 'Psychiatric genetic counseling: A mapping exercise', American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, vol. 180, pp. 523 - 532, http://dx.doi.org/10.1002/ajmg.b.32735

Li A; Geyer FC; Blecua P; Lee JY; Selenica P; Brown DN; Pareja F; Lee SSK; Kumar R; Rivera B; Bi R; Piscuoglio S; Wen HY; Lozada JR; Gularte-Mérida R; Cavallone L; Aghmesheh M; Amor D; Andrews L; Antill Y; Balleine R; Beesley J; Blackburn A; Bogwitz M; Brown M; Burgess M; Burke J; Butow P; Caldon L; Campbell I; Christian A; Clarke C; Cohen P; Crook A; Cui J; Cummings M; Dawson SJ; De Fazio A; Delatycki M; Dobrovic A; Dudding T; Duijf P; Edkins E; Edwards S; Farshid G; Fellows A; Field M; Flanagan J; Fong P; Forbes J; Forrest L; Fox S; French J; Friedlander M; Ortega DG; Gattas M; Giles G; Gill G; Gleeson M; Greening S; Haan E; Harris M; Hayward N; Hickie I; Hopper J; Hunt C; James P; Jenkins M; Kefford R; Kentwell M; Kirk J; Kollias J; Lakhani S; Lindeman G; Lipton L; Lobb L; Lok S; Macrea F; Mann G; Marsh D; McLachlan SA; Meiser B; Milne R; Nightingale S; O’Connell S; Pachter N; Patterson B; Phillips K; Saleh M; Salisbury E; Saunders C; Saunus J; Scott C; Scott R; Sexton A; Shelling A; Simpson P; Spigelman A; Spurdle M; Stone J, 2019, 'Publisher Correction: Homologous recombination DNA repair defects in PALB2-associated breast cancers (npj Breast Cancer, (2019), 5, 1, (23), 10.1038/s41523-019-0115-9)', npj Breast Cancer, vol. 5, http://dx.doi.org/10.1038/s41523-019-0140-8

Figlioli G; Bogliolo M; Catucci I; Caleca L; Lasheras SV; Pujol R; Kiiski JI; Muranen TA; Barnes DR; Dennis J; Michailidou K; Bolla MK; Leslie G; Aalfs CM; Balleine R; Baxter R; Braye S; Carpenter J; Dahlstrom J; Forbes J; Lee CS; Marsh D; Morey A; Pathmanathan N; Scott R; Simpson P; Spigelman A; Wilcken N; Yip D; Zeps N; Adank MA; Adlard J; Agata S; Cadoo K; Agnarsson BA; Ahearn T; Aittomäki K; Ambrosone CB; Andrews L; Anton-Culver H; Antonenkova NN; Arndt V; Arnold N; Aronson KJ; Arun BK; Asseryanis E; Auber B; Auvinen P; Azzollini J; Balmaña J; Barkardottir RB; Barrowdale D; Barwell J; Beane Freeman LE; Beauparlant CJ; Beckmann MW; Behrens S; Benitez J; Berger R; Bermisheva M; Blanco AM; Blomqvist C; Bogdanova NV; Bojesen A; Bojesen SE; Bonanni B; Borg A; Brady AF; Brauch H; Brenner H; Brüning T; Burwinkel B; Buys SS; Caldés T; Caliebe A; Caligo MA; Campa D; Campbell IG; Canzian F; Castelao JE; Chang-Claude J; Chanock SJ; Claes KBM; Clarke CL; Collavoli A; Conner TA; Cox DG; Cybulski C; Czene K; Daly MB; de la Hoya M; Devilee P; Diez O; Ding YC; Dite GS; Ditsch N; Domchek SM; Dorfling CM; dos-Santos-Silva I; Durda K, 2019, 'The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer', npj Breast Cancer, vol. 5, http://dx.doi.org/10.1038/s41523-019-0127-5

Tutty E; Petelin L; McKinley J; Young MA; Meiser B; Rasmussen VM; Forbes Shepherd R; James PA; Forrest LE, 2019, 'Evaluation of telephone genetic counselling to facilitate germline BRCA1/2 testing in women with high-grade serous ovarian cancer', European Journal of Human Genetics, vol. 27, pp. 1186 - 1196, http://dx.doi.org/10.1038/s41431-019-0390-9

Cheng L; Meiser B, 2019, 'The relationship between psychosocial factors and biomarkers in cancer patients: A systematic review of the literature', European Journal of Oncology Nursing, vol. 41, pp. 88 - 96, http://dx.doi.org/10.1016/j.ejon.2019.06.002

Best MC; Bartley N; Jacobs C; Juraskova I; Goldstein D; Newson AJ; Savard J; Meiser B; Ballinger M; Napier C; Thomas D; Biesecker B; Butow P; Tucker K; Schlub T; Vines R; Vines K; Kirk J; Young MA, 2019, 'Patient perspectives on molecular tumor profiling: "why wouldn't you?"', BMC Cancer, vol. 19, pp. 753, http://dx.doi.org/10.1186/s12885-019-5920-x

Smith SK; Cabrera-Aguas M; Shaw J; Shepherd H; Naehrig D; Meiser B; Jackson M; Saade G; Bucci J; Halkett GKB; Turner RM; Milross C; Dhillon HM, 2019, 'A low literacy targeted talking book about radiation therapy for cancer: development and acceptability', Supportive Care in Cancer, vol. 27, pp. 2057 - 2067, http://dx.doi.org/10.1007/s00520-018-4446-0

Thavaneswaran S; Napier C; Goldstein D; Meiser B; Butow P; Thomas DM; Ballinger ML; Best M, 2019, 'Medical oncologists’ experience with returning molecular tumor profiling to patients.', Journal of Clinical Oncology, vol. 37, pp. 10521 - 10521, http://dx.doi.org/10.1200/jco.2019.37.15_suppl.10521

Kaur R; Meiser B; Zilliacus E; Tim Wong WK; Woodland L; Watts K; Tomkins S; Kissane D; Girgis A; Butow P; Hale S; Perry A; Aranda SK; Shaw T; Tebble H; Norris C; Goldstein D, 2019, 'Evaluation of an online communication skills training programme for oncology nurses working with patients from minority backgrounds', Supportive Care in Cancer, vol. 27, pp. 1951 - 1960, http://dx.doi.org/10.1007/s00520-018-4507-4

Josephi-Taylor S; Barlow-Stewart K; Selvanathan A; Roscioli T; Bittles A; Meiser B; Worgan L; Rajagopalan S; Colley A; Kirk EP, 2019, 'User Acceptability of Whole Exome Reproductive Carrier Testing for Consanguineous Couples in Australia', Journal of Genetic Counseling, vol. 28, pp. 240 - 250, http://dx.doi.org/10.1007/s10897-018-0298-5

Mills L; Meiser B; Ahmad R; Schofield PR; Peate M; Levitan C; Trevena L; Barlow-Stewart K; Dobbins T; Christensen H; Sherman KA; Dunlop K; Mitchell PB, 2019, 'A cluster randomized controlled trial of an online psychoeducational intervention for people with a family history of depression 11 Medical and Health Sciences 1117 Public Health and Health Services 11 Medical and Health Sciences 1103 Clinical Sciences', BMC Psychiatry, vol. 19, pp. 29, http://dx.doi.org/10.1186/s12888-018-1994-2

Sutherland S; Meiser B; Kaur R; Mitchell G; Kirk J; Peate M; Tim Wong WK; Goodwin A, 2019, 'Assessing the medical workforces perceived barriers to the prescription of risk-reducing medication for women at high-risk of breast cancer', Breast Journal, vol. 25, pp. 34 - 40, http://dx.doi.org/10.1111/tbj.13157

Grimmett C; Brooks C; Recio-Saucedo A; Armstrong A; Cutress RI; Gareth Evans D; Copson E; Turner L; Meiser B; Wakefield CE; Eccles D; Foster C, 2019, 'Development of Breast Cancer Choices: a decision support tool for young women with breast cancer deciding whether to have genetic testing for BRCA1/2 mutations', Supportive Care in Cancer, vol. 27, pp. 297 - 309, http://dx.doi.org/10.1007/s00520-018-4307-x


Back to profile page